$ZYNE Pharmaceuticals Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel™(CBD Gel) in Fragile X Syndrome
#pressrelease https://t.co/nNI1myVNbE
#ClinicalTrials #Zynerba #Pharmaceuticals #finance #investment #investor #stocks #FilingSearch
Picture Credit: ZYNERBA https://t.co/FunDkaNwum